Reinhard Vonthein, Benito Baldauf, Stefan Borov, Ernest W Lau, Marzia Giaccardi, Ojan Assadian, Christelle Haddad, Philippe Chévalier, Kerstin Bode, Paul Foley, Honey Thomas, Niall G Campbell, Stephanie Fichtner, Luca Donazzan, Felix Pescoller, Rainer Oberhollenzer, Roberto Cemin, Hendrik Bonnemeier
INTRODUCTION: Infection is a significant complication of cardiac implantable electronic device (CIED) therapy. The European TauroPace™ Registry investigates the safety and efficacy of TauroPace™ (TP), an antimicrobial solution containing taurolidine, designed to prevent CIED infections. METHODS: This multicenter study included patients undergoing CIED procedures at participating centers where TP was used as a disinfectant for external hardware surfaces and an antiseptic for irrigating surgical sites...
October 4, 2024: Journal of Cardiothoracic Surgery